Quirónsalud Granted Extension to Launch Madrid Laboratory Amid Conflict with Ribera Salud. Madrid authorities have given Quirónsalud a one-week extension to prepare for taking over management of a major laboratory. Ribera Salud objected to the delay, accusing its competitor of violating workers’ rights. The dispute affects 1.4 million residents in the region.
A conflict has erupted in Madrid over the transfer of management of the region’s largest laboratory: Quirónsalud, which won a five-year contract, has been granted a one-week extension by the government before commencing operations. The decision was made after the company stated it needed time to install new equipment. However, behind these technical reasons lies tension between the new and former operators, as well as with the laboratory staff.
The laboratory in San Sebastián de los Reyes serves 1.4 million residents and had previously been managed by Ribera Salud since 2008. According to the terms of the tender, after the contract was signed, a one-month transition period with both companies operating jointly was to begin on May 13 to ensure a smooth handover. However, the transition will now be delayed by more than a month—until June 22. Madrid authorities insist that, formally, the terms have not been violated, but Ribera Salud was not officially notified about the postponement and has opposed the delay, calling it unjustified.
The situation is further complicated by a dispute over the future of 249 laboratory employees. Ribera Salud believes that Quirónsalud is obligated to hire the staff while preserving all employment rights, including seniority, while Quirónsalud insists on ending previous contracts and having severance paid by the former employer. About half of the workers have refused to sign new contracts due to the lack of seniority guarantees and controversial clauses allowing their transfer to other centers.
Dissatisfaction is growing within the team: the UGT union notes that many employees had already planned to change jobs or take vacations based on the original handover dates. In a letter to the unions, Ribera Salud expressed solidarity with the staff and emphasized that the decision to extend the transition period was made without its involvement. The company also insists on an immediate completion of the transfer to avoid further uncertainty for the personnel.
The laboratory management contract is valued at 120 million euros over five years. For Quirónsalud, this is in addition to existing agreements with the Madrid government, including the management of three major hospitals and access to Fundación Jiménez Díaz. After losing the laboratory, Ribera Salud retains only the contract with Hospital de Torrejón, around which questions had previously arisen about reduced healthcare services in favor of financial optimization, as noted by EL PAÍS.
The transfer of the laboratory to a new operator has become one of the most high-profile conflicts in Madrid's healthcare system in recent years. It affects not only the interests of employees and companies but also the stability of medical services for millions of residents. Similar disputes over transferring public contracts to private operators have repeatedly drawn public attention—for example, in the case of the permit for extraction in the Ambros lagoons, when the authorities' decision sparked protests from environmentalists and an investigation, as detailed in an article on russpain.com.
For reference: Quirónsalud receives about €1 billion annually from Madrid authorities under various contracts. Ribera Salud is a major player in the private healthcare market, based in Valencia. In recent years, competition between these companies has intensified amid an increase in public healthcare tenders. According to industry associations, such transitions are often accompanied by disputes over employees’ rights and the conditions for transferring infrastructure.
